How do we enhance protective immunity to COVID-19 in lung transplant recipients?
- PMID: 36657779
- DOI: 10.1183/13993003.01723-2022
How do we enhance protective immunity to COVID-19 in lung transplant recipients?
Conflict of interest statement
Conflict of interest: D.W.J. Griffin has nothing to declare. J.H. McMahon has received funding from the Medical Research Future Foundation (MRF2014921) to conduct a trial of COVID-19 booster vaccination in immunocompromised hosts.
Comment on
-
Efficacy of three COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study.Eur Respir J. 2023 Jan 19;61(1):2200502. doi: 10.1183/13993003.00502-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36265877 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical